Financials
- Market Capitalization 12.85 B
- Employee 839
- Founded 2015
- CEO Neil Kumar
- Website www.bridgebio.com
- Headquarter Delaware, United States
- FIGI BBG00P9KDZK6
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-20.24
売上高対価格比率
29.18
Related tickers
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 721 | SMMT Summit Therapeutics Inc. - Common Stock | 17.13 USD | -2.62% | -2.11% | -5.20% | -13.75% | 13.67 B USD | ||
| 744 | CORT Corcept Therapeutics Incorporated - Common Stock | 121.19 USD | 0.00% | -0.83% | +6.89% | +65.18% | 13.10 B USD | ||
| 770 | HALO Halozyme Therapeutics, Inc. - Common Stock | 111.08 USD | +0.60% | +2.03% | +2.85% | +66.29% | 12.61 B USD | ||
| 822 | TECH Bio-Techne Corp - Common Stock | 72.56 USD | +0.14% | -0.03% | +0.48% | +23.55% | 11.38 B USD |